MoneyWorks4Me

Gujarat Themis Biosyn informs about revised disclosure

27 Jul 2021 Evaluate
In furtherance to letter dated 26th July, 2021, Gujarat Themis Biosyn has informed that it enclosed the revised disclosure under Regulation 10(5) of SAST 2011, as required. In the revised disclosure filed, there is a correction made in point no 11 thereof.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..